Genfit
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Genfit
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
/ 
Frequently asked questions
To buy Genfit stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Genfit by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Genfit is GNFT:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Genfit has its primary listing on Euronext Paris. You can trade Genfit with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Genfit is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Genfit as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Genfit.